1. Sola, P., P.T. Krishnamurthy, M. Kumari, G. Byran, H.V. Gangadharappa and K.K. Garikapati, 2022. Neuroprotective approaches to halt Parkinson's disease progression. Neurochem. Int., Vol. 158. 10.1016/j.neuint.2022.105380.
   CrossRef  |  Direct Link  |  
2. Praveen, T.K., H.V. Gangadharappa, A.S.A. Lila, A. Moin and K. Mehmood et al., 2022. Inflammation targeted nanomedicines: Patents and applications in cancer therapy. Semin. Cancer Biol., 86: 645-663.
   CrossRef  |  Direct Link  |  
3. Mayuri, M., P.T. Krishnamurthy and T.M. Vijayakumar, 2022. NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell line. Exp. Mol. Pathol., Vol. 127. 10.1016/j.yexmp.2022.104817.
   CrossRef  |  Direct Link  |  
4. Manandhar, S., K.S.R. Pai, P.T. Krishnamurthy, A.V.V.V.R. Kiran and G.K. Kumari, 2022. Identification, virtual screening and molecular dynamic analysis of novel TMPRSS2 inhibitors from natural compound database as potential entry-blocking agents in SARS-CoV-2 therapy. Struct. Chem., 33: 1609-1617.
   CrossRef  |  Direct Link  |  
5. Li, Y., K.S. Nagashree, G. Byran and P.T. Krishnamurthy, 2022. Identification of selective PPAR-γ modulators by combining pharmacophore modeling, molecular docking, and adipogenesis assay. Appl. Biochem. Biotechnol., 10.1007/s12010-022-04190-2.
   CrossRef  |  Direct Link  |  
6. Kiran, A.V.V.V.R., G.K. Kumari and P.T. Krishnamurthy, 2022. Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer. Invest. New Drugs, 40: 1-9.
   CrossRef  |  Direct Link  |  
7. Khaydarov, R., O. Gapurova, M. Abdukhakimov, I. Sadikov and I. Garipov et al., 2022. Antimicrobial properties of nanofiltration membranes modified with silver nanoparticles. Emergent Mater., 5: 1477-1483.
   CrossRef  |  Direct Link  |  
8. Khaydarov, R., M. Abdukhakimov, I. Garipov, I. Sadikov, P.T. Krishnamurthy and S. Evgrafova, 2022. Silver-containing cation exchange resin: Synthesis and application. Mater. Sci., 28: 89-92.
   CrossRef  |  Direct Link  |  
9. Jayaram, S., P.T. Krishnamurthy, M. Joshi and V. Kumar, 2022. Nrf2 as a Potential Therapeutic Target for Treatment of Huntington’s Disease. In: From Pathophysiology to Treatment of Huntington's Disease, Szejko, N. (Ed.), IntechOpen, London, UK, ISBN: 978-1-80355-426-6, .
   CrossRef  |  Direct Link  |  
10. Garikapati, K.K., V.V.V.R.K. Ammu, P.T. Krishnamurthy, S.T. Narenderan, B. Babu and K. Nagappan, 2022. Quantification of rosiglitazone in rat plasma and tissues via LC–MS/MS: Method development, validation, and application in pharmacokinetic and tissue distribution studies. Biomed. Chromatogr., Vol. 36. 10.1002/bmc.5326.
    CrossRef  |  Direct Link  |  
11. Esakkimuthukumar, M., A.K. Swaroop, S.K. Patnaik, R.R. Kumar, T.K. Praveen, M.R. Naik and S. Jubie, 2022. A novel family of small molecule HIF-1 alpha stabilizers for the treatment of diabetic wounds; an integrated in silico, in vitro, and in vivo strategy. RSC Adv., 12: 31293-31302.
    CrossRef  |  Direct Link  |  
12. Daniels, J.A., 2022. Advances in Environmental Research. Nova Science Publishers, Hauppauge, New York, ISBN: 979-8-88697-362-4 Pages: 208.
    CrossRef  |  Direct Link  |  
13. Sulaiman, C.T., M. Deepak, T.K. Praveen, K.R. Lijini, E.M. Anandan, M. Salman and I. Balachandran, 2021. Purification of bhallathaka (Semecarpus anacardium L.f.) enhanced anti-cancer activity. Regul. Toxicol. Pharmacol., Vol. 122. 10.1016/j.yrtph.2021.104898.
    CrossRef  |  Direct Link  |  
14. Sanapalli, B.K.R., V. Yele, M.K. Singh, P.T. Krishnamurthy and V.V.S.R. Karri, 2021. Preclinical models of diabetic wound healing: A critical review. Biomed. Pharmacother., Vol. 142. 10.1016/j.biopha.2021.111946.
    CrossRef  |  Direct Link  |  
15. Sanapalli, B.K.R., K.C. Gounder, N.S. Ambhore, G. Kuppuswamy, P.T. Krishnamurthy and V.V.S.R. Karri, 2021. Doxycycline loaded collagen-chitosan composite scaffold for the accelerated healing of diabetic wounds. JoVE J., Vol. 174. 10.3791/62184.
    CrossRef  |  Direct Link  |  
16. Sajini, D.V., P.T. Krishnamurthy and A.C. Kandiyil, 2021. Neuroprotective activities of orientin: A Review. Curr. Traditional Med., Vol. 8. 10.2174/2215083807666210913104505.
    CrossRef  |  Direct Link  |  
17. Magham, S.V., P.T. krishnamurthy, N. Shaji, L. Mani and S. Balasubramanian, 2021. Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials. J. Neurosci. Res., 99: 2888-2905.
    CrossRef  |  Direct Link  |  
18. Lakshmanan, K., T. K. Praveen, S.R.K. Pai, K. Rajagopal and G. Byran, 2021. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and in vitro evaluation J. Biomol. Struct. Dyn., 10.1080/07391102.2021.1957717.
    CrossRef  |  Direct Link  |  
19. Kumari, M., P.T. Krishnamurthy, S.k.S.S. Pinduprolu and P. Sola, 2021. DR-5 and DLL-4 mAb functionalized SLNs of gamma-secretase inhibitors- An approach for TNBC treatment. Adv. Pharm. Bull., 11: 618-623.
    CrossRef  |  Direct Link  |  
20. Kumari, G.K., A.V.V.V.R. Kiran and P.T. Krishnamurthy, 2021. Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancer. Med. Oncol., Vol. 38. 10.1007/s12032-021-01521-x.
    CrossRef  |  Direct Link  |  
21. Kumari G.K., P.T. Krishnamurthy, R.K.V.V.V. Ammu, K. Vishwanath, S.T. Narenderan, B. Babu and N. Krishnaveni, 2021. Development and validation of a sensitive LC-MS/MS method for pioglitazone: Application towards pharmacokinetic and tissue distribution study in rats. RSC Adv., 11: 11437-11443.
    CrossRef  |  Direct Link  |  
22. Kiran, A.V.V.V.R., G.K. Kumari, P.T. Krishnamurthy, P.K. Chintamaneni and S.K.S.S. Pindiprolu, 2021. Carbon Nanotubes in Cancer Therapy. In: Handbook of Carbon Nanotubes, Abraham, J., S. Thomas and N. Kalarikkal (Eds.), Springer International Publishing, Cham, Switzerland, ISBN: 978-3-319-70614-6, pp: 1-33.
    CrossRef  |  Direct Link  |  
23. Kiran, A.V.V.V.R., G.K. Kumari, P.T. Krishnamurthy and R.R. Khaydarov, 2021. Tumor microenvironment and nanotherapeutics: Intruding the tumor fort. Biomater. Sci., 9: 7667-7704.
    CrossRef  |  Direct Link  |  
24. Kaviarasan, L., E. Eldhose, P.T. Krishnamurthy, K. Rajagopal, M. Mohammed, P. Prudviraj and G. Byran, 2021. 1,3,4-thiadiazolo (3,2-Α) pyrimidine-6-carbonitrile scaffold as PARP1 inhibitors. Anti-Cancer Agents Med. Chem., 21: 2050-2065.
    CrossRef  |  Direct Link  |  
25. Kakhramonovich, A.M., G.I. Tagirovich, K. Ra, K.R. Rashidovich and G.O. Urumbaevna, 2021. Novel ion exchange fibers for wastewater treatment from heavy metal ions. Manage. Technosphere, 4: 88-97.
    CrossRef  |  Direct Link  |  
26. Jayaram, S., P.T. Krishnamurthy, 2021. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators. Neurochem. Int., Vol. 145. 10.1016/j.neuint.2021.105014.
    CrossRef  |  Direct Link  |  
27. Chintamaneni, P.K., P.T. Krishnamurthy and S.K.S.S. Pindiprolu, 2021. Polysorbate-80 surface modified nano-stearylamine BQCA conjugate for the management of Alzheimer's disease. RSC Adv., 11: 5325-5334.
    CrossRef  |  Direct Link  |  
28. Baboota S. and J. Ali, 2021. Nanocarriers for the Delivery of Combination Drugs. Elsevier, Amsterdam, Netherlands, ISBN: 978-0-12-820779-6 Pages: 508.
    CrossRef  |  Direct Link  |  
29. Sravanthi, B., L. Kaviarasan, T.K. Praveen, P.S.S.S. Kiran, C. Pavankumar and B. Gowramma, 2020. Synthesis and pharmacological evaluation of 1,3,4-thiadiazole bearing pyrimidine derivatives as STAT₃ inhibitor for treatment of breast cancer. J. Iran. Chem. Soc., 17: 2359-2370.
    CrossRef  |  Direct Link  |  
30. Pindiprolu, S.K.S.S., P.T. Krishnamurthy, C. Dev and P.K. Chintamaneni, 2020. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Chem. Phys. Lipids, Vol. 235. 10.1016/j.chemphyslip.2020.105033.
    CrossRef  |  Direct Link  |  
31. Kumari, M., P.T. Krishnamurthy and P. Sola, 2020. Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer. Curr. Cancer Drug Targets, 20: 559-572.
    CrossRef  |  Direct Link  |  
32. Krishnamurthy, P.T., 2020. Coronavirus disease 2019: Virology and drug targets. Infect. Disord. Drug Targets, 10.2174/1871526520666201209145302.
    CrossRef  |  Direct Link  |  
33. Krishna, S., B. Gowramma, M. Mohammed, R. Kalirajan, L. Kaviarasan and T.K. Praveen, 2020. Synthesis, in silico and in vivo evaluation of novel 1, 3, 4-thiadiazole analogues as novel anticancer agents. Lett. Drug Des. Discovery, 17: 434-444.
    CrossRef  |  Direct Link  |  
34. Kiran, A.V.V.V.R., G.K. Kumari and P.T. Krishnamurthy, 2020. Carbon nanotubes in drug delivery: Focus on anticancer therapies. J. Drug Delivery Sci. Technol., Vol. 59. 10.1016/j.jddst.2020.101892.
    CrossRef  |  Direct Link  |  
35. Anisetty, V., A. Wadhwani, D. Mani, T.K. Praveen and V. Patel et al., 2020. In vitro efficacy of anti-HSV drugs on breast cancer cells MCF-7 & MDA-MB-231-A drug repurposing approach. Int. J. Pharm. Res., 12: 514-523.
    CrossRef  |  Direct Link  |  
36. Reddy, P.R.K., J. Saravanan and T.K. Praveen, 2019. Evaluation of neuroprotective activity of Melissa officinalis in MPTP model of Parkinson's disease in mice. Res. J. Pharm. Technol., 12: 2103-2108.
    CrossRef  |  Direct Link  |  
37. Pindiprolu, S.K.S.S., P.K. Chintamaneni, P.T. Krishnamurthy and K.R.S. Ganapathineedi, 2019. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells. Drug Dev. Ind. Pharm., 45: 304-313.
    CrossRef  |  Direct Link  |  
38. Nagashree, K.S. and P.T. Krishnamurthy, 2019. Comparative analysis of ligand binding modes of ppar-γ full and partial agonists. Int. Res. J. Pharm., 10: 85-93.
    CrossRef  |  Direct Link  |  
39. Lakkappa, N., P.T. Krishnamurthy, M.D. Pandareesh, B.D. Hammock and S.H. Hwang, 2019. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson’s disease. NeuroToxicology, 70: 135-145.
    CrossRef  |  Direct Link  |  
40. Janani, K.A., T.K. Praveen and A. Wadhwani, 2019. Experimental models to study tumour angiogenesis-in-vitro, ex-vivo and in-vivo approach. Int. J. Pharm. Sci. Res., 10: 3648-3659.
    CrossRef  |  Direct Link  |  
41. Jana, B.A., P.K. Chintamaneni, P.T. Krishnamurthy, A. Wadhwani and S.K. Mohankumar, 2019. Cytosolic lipid excess-induced mitochondrial dysfunction is the cause or effect of high fat diet-induced skeletal muscle insulin resistance: A molecular insight. Mol. Biol. Rep., 46: 957-963.
    CrossRef  |  Direct Link  |  
42. Ghanta, V.R., N. Madala, A. Pasula, S.K.S.S. Pindiprolu, K.S. Battula, P.T. Krishnamurthy and B. Raman, 2019. Novel dermacozine-1-carboxamides as promising anticancer agents with tubulin polymerization inhibitory activity. RSC Adv., 9: 18670-18677.
    CrossRef  |  Direct Link  |  
43. Garikapati, K.K., V.V.V.R.K. Ammu, P.T. Krishnamurthy, P.K. Chintamaneni and S.K.S.S. Pindiprolu, 2019. Type-II endometrial cancer: Role of adipokines. Arch. Gynecology Obstetrics, 300: 239-249.
    CrossRef  |  Direct Link  |  
44. Garikapati, K.K., V.V.V.R.K. Ammu, P.T. Krishnamurthy, P.K. Chintamaneni and S.K.S.S. Pindiprolu, 2019. Possible role of thiazolidinedione in the management of type-II endometrial cancer. Med. Hypotheses, 126: 78-81.
    CrossRef  |  Direct Link  |  
45. Chinnappan, S.M., A. George, P. Thaggikuppe, Y.K. Choudhary, V.K. Choudhary, Y. Ramani and R. Dewangan, 2019. Nephroprotective effect of herbal extract Eurycoma longifolia on paracetamol-induced nephrotoxicity in rats. Evidence-Based Complementary Altern. Med., Vol. 2019. 10.1155/2019/4916519.
    CrossRef  |  Direct Link  |  
46. Ammu, V.V.V.R.K., K.K. Garikapati, P.T. Krishnamurthy, P.K. Chintamaneni and S.K.S.S. Pindiprolu, 2019. Possible role of PPAR-γ and COX-2 receptor modulators in the treatment of non-Small Cell lung carcinoma. Med. Hypotheses, 124: 98-100.
    CrossRef  |  Direct Link  |  
47. Thondawada, M., A.D. Wadhwani, D.S. Palanisamy, H.S. Rathore and R.C. Gupta et al., 2018. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. Drug Dev. Ind. Pharm., 44: 1120-1129.
    CrossRef  |  Direct Link  |  
48. Rao, P.V., P.T. Krishnamurthy, S.P. Dahapal and P.K. Chinthamaneni, 2018. An updated review on “Miracle tree”: Moringa oleifera. Res. J. Pharmacogn. Phytochem., 10: 101-108.
    CrossRef  |  Direct Link  |  
49. Pindiprolu, S.S.S.K., P.T. Krishnamurthy and P.K. Chintamaneni, 2018. Lipid bioconjugated nanocarriers for potentiating chemotherapeutic efficacy and preventing metastasis in triple negative breast cancer. Eur. J. Cancer, Vol. 92. 10.1016/S0959-8049(18)30592-6.
    CrossRef  |  Direct Link  |  
50. Pindiprolu, S.K.S.S., P.T. Krishnamurthy, P.K. Chintamaneni and V.V.S.R. Karri, 2018. Nanocarrier based approaches for targeting breast cancer stem cells. Artif. Cells Nanomed. Biotechnol., 46: 885-898.
    CrossRef  |  Direct Link  |  
51. Pindiprolu, S.K.S.S., P.T. Krishnamurthy and P.K. Chintamaneni, 2018. Pharmacological targets of breast cancer stem cells: A review. Naunyn-Schmiedeberg's Arch. Pharmacol., 391: 463-479.
    CrossRef  |  Direct Link  |  
52. Lakkappa, N., P.T. Krishnamurthy, K. Yamjala, S.H. Hwang, B.D. Hammock and B. Babu, 2018. Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC–MS/MS method development. J. Pharm. Biomed. Anal., 149: 457-464.
    CrossRef  |  Direct Link  |  
53. Gowramma, B., T.K. Praveen, S. Gomathy, R. Kalirajan, B. Babu and N. Krishnavenic, 2018. Synthesis of 2-(Bis (2-chloroethyl)amino)-N-(5-substitutedphenyl)- 1,3,4- thiadiazol-2-Yl)acetohydrazide and evaluation of anticancer activity. Curr. Bioact. Compd., 14: 309-316.
    CrossRef  |  Direct Link  |  
54. Chintamaneni, P.K., P.T. Krishnamurthy, P.V. Rao and S.S.S. Pindiprolu, 2017. Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer’s disease. Med. Hypotheses, 101: 17-22.
    CrossRef  |  Direct Link  |  
55. Chalichem, N.S.S., C. Gonugunta, P.T. Krishnamurthy and B. Duraiswamy, 2017. DPP4 inhibitors can be a drug of choice for type 3 diabetes: A mini review. Am. J. Alzheimers Dis. Other Dementias, 32: 444-451.
    CrossRef  |  Direct Link  |  
56. Bando, Y. and S. Yoshida, 2017. Poster sessions WTH Wednesday/Thursday. J. Neurochem., 142: 165-259.
    CrossRef  |  Direct Link  |  
57. Tummala, S., K. Gowthamarajan, M.N.S. Kumar, T.K. Praveen, K. Yamjala, N.S. Tripuraneni and A. Prakash, 2016. Formulation and optimization of oxaliplatin immuno-nanoparticles using box-Behnken design and cytotoxicity assessment for synergistic and receptor-mediated targeting in the treatment of colorectal cancer. Artif. Cells Nanomed. Biotechnol., 44: 1835-1850.
    CrossRef  |  Direct Link  |  
58. Tummala, S., G. Kuppusamy, M.N.S. Kumar, T.K. Praveen and A. Wadhwani, 2016. 5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer. Drug Delivery, 23: 2902-2910.
    CrossRef  |  Direct Link  |  
59. Lakkappa, N., P.T. Krishnamurthy, B.D. Hammock, D. Velmurugan and M.M.S. Bharath, 2016. Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders. Med. Hypotheses, 93: 161-165.
    CrossRef  |  Direct Link  |  
60. Basavan, D., N.S. Chalichem, P. Krishnamurthy, P. Chintamaneni and B. Vanitha, 2016. Possible targets of herbals for type 3 diabetes: A review. Curr. Trad. Med., 2: 148-185.
    CrossRef  |  Direct Link  |  
61. Shrestha, A., P.T. Krishnamurthy, P. Thomas, B.D. Hammock and S.H. Hwang, 2014. Soluble epoxide hydrolase inhibitor,t-TUCB, protects against myocardial ischaemic injury in rats. J. Pharm. Pharmacol., 66: 1251-1258.
    CrossRef  |  Direct Link  |  
62. Praveen, T., M. Chandrasekar and M. Nanjan, 2013. Novel glitazones with diverse peroxisome proliferator activated receptor modulatory potential. Curr. Bioact. Compd., 9: 221-234.
    CrossRef  |  Direct Link  |  
63. Krishnamurthy, P.T., M.J.N. Chandrasekar and M.J. Nanjan, 2013. Newer approaches to the discovery of glitazones. Mini-Rev. Org. Chem., 10: 66-72.
    CrossRef  |  Direct Link  |  
64. Krishnamurthy, P. and A. Wadhwani, 2012. Antioxidant Enzymes and Human Health. In: Antioxidant Enzyme, El-Missiry, M.A. (Ed.), IntechOpen, London, UK, ISBN: 978-953-51-0789-7.
    CrossRef  |  Direct Link  |  
65. El-Missiry, M.A., 2012. Antioxidant Enzyme. IntechOpen, London, UK, ISBN: 978-953-51-0789-7, Pages: 412.
    CrossRef  |  Direct Link  |  
66. Muruganantham, N., K.H. Basavaraj, S.P. Dhanabal, T.K. Praveen, N.M. Shamasundar and K.S. Rao, 2011. Screening of Caesalpinia bonduc leaves for antipsoriatic activity. J. Ethnopharmacol., 133: 897-901.
    CrossRef  |  Direct Link  |  
67. Praveen, T K., S. Dharmaraj, J. Bajaj, S.P. Dhanabal, S. Manimaran, M.J. Nanjan and R. Razdan, 2009. Hepatoprotective activity of petroleum ether, diethyl ether and methanol extract of Scoparia dulcis L. against CCl₄-induced acute liver injury in mice. Indian J. Pharmacol., 41: 110-114.
    CrossRef  |  PubMed  |  Direct Link  |  
68. Nanjan, M.J., T.K. Praveen, B. Suresh, J. Vergheese, B.J. Desai and B.R.P. Kumar, 2008. CoMFA study on thiazolidine-2,4-diones for their antihyperglycemic activity. Lett. Drug Des. Discovery, 5: 79-87.
    CrossRef  |  Direct Link  |  
69. Kumar, B.R.P., T.K. Praveen, M.J. Nanjan, M.D. Karvekar and B. Suresh, 2007. Serum glucose and triglyceride lowering activity of some novel glitazones against dexamethasone-induced hyperlipidemia and insulin resistance. Indian J. Pharmacol., 39: 299-302.
    CrossRef  |  Direct Link  |